<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Cmtausap - Latest News</title>
<link href="https://news.newswirebiz.com/rss/cmtausap/latest.xml"></link>
<updated>2026-07-21T11:59:20+00:00</updated>
<id>urn:uuid:9daca2fb-ae92-57a1-8736-a881b4b4d2a8</id>
<entry>
<title>Charcot-Marie-Tooth Association Enters Collaboration with Affectis to Advance Therapies for CMT1A</title>
<link href="https://news.newswirebiz.com/@cmtausap/charcot-marie-tooth-association-enters-collaboration-with-affectis-to-advance-therapies-for-cmt1a-rb68qp5rb3dj"></link>
<id>urn:uuid:7eb0ec4b-cca0-725f-df53-d61a9f6a679a</id>
<summary type="html"><![CDATA[The Charcot-Marie-Tooth Association (CMTA) announced today that it has entered into a collaboration with Affectis Pharmaceuticals AG to evaluate the efficacy of advanced Affectis compounds in neurological and behavioral models of CMT1A.]]></summary>
<updated>2015-04-21T12:40:05+00:00</updated>
</entry>
</feed>